PHILADELPHIA, Aug. 31, 2026 (GLOBE NEWSWIRE) --
Aardvark Therapeutics, Inc. (NASDAQ: AARD):
Grabar Law Office is investigating claims on behalf of Aardvark Therapeutics, Inc. (NASDAQ: AARD) shareholders who purchased shares on or shortly after the Company’s February 13, 2025, initial public offering (IPO) and have continued to hold their shares.
What is This Investigation About? The investigation follows the filing of a securities class action against Aardvark and certain of its officers and directors alleging violations of the federal securities laws in connection with statements concerning the safety and prospects of the Company’s lead drug candidate, ARD-101.
If you purchased Aardvark Therapeutics, Inc. (NASDAQ: AARD) shares on or shortly after the Company’s February 13, 2025 IPO, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever through a shareholder governance action. You are encouraged to visit https://grabarlaw.com/the-latest/aardvark-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.
What is Alleged? Aardvark (NASDAQ: AARD) completed its IPO on or about February 13, 2025. The Company sold approximately 5.9 million shares at $16.00 per share, generating approximately $87.6 million in net proceeds after underwriting discounts and commissions.
According to the recently filed securities complaint, Aardvark’s offering documents represented that ARD-101 had been “well-tolerated” in earlier clinical trials, had limited systemic absorption, and had demonstrated no serious adverse events. The complaint alleges that the offering documents were materially false or misleading because they failed to disclose that ARD-101 was allegedly less safe than investors had been led to believe and that its clinical, regulatory, and commercial prospects were therefore overstated.
The complaint further alleges that similar representations concerning ARD-101’s safety continued after the IPO. For example, Company representatives subsequently described ARD-101 as having a “very, very clean” safety profile and represented that its limited systemic exposure reduced the likelihood of side effects.
On February 27, 2026, Aardvark announced that it was voluntarily pausing enrollment and dosing in the Phase 3 HERO trial after identifying reversible cardiac observations during safety monitoring in a healthy-volunteer study. Following the announcement, Aardvark’s stock price allegedly declined approximately 56%, closing at $5.47 per share on March 2, 2026.
Then, on May 14, 2026, Aardvark announced that the FDA had placed a full clinical hold on the investigational new drug application for ARD-101, including the Phase 3 HERO trial and its open-label extension. According to the complaint, Aardvark’s stock declined another 32.1% the following day, closing at $4.57 per share.
What Can You Do Now? If you purchased Aardvark shares at or shortly after the February 13, 2025 IPO, and continue to own those shares, you may have important rights concerning the Company’s management. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever through a shareholder governance action. Please visit https://grabarlaw.com/the-latest/aardvark-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more. #AARD $AARD #Aardvark
Flotek Industries, Inc. (NYSE: FTK):
Grabar Law Office is investigating potential claims on behalf of shareholders of Flotek Industries, Inc. (NYSE: FTK).
What is This Investigation About? The investigation concerns possible breaches of fiduciary duty and other corporate governance issues relating to the Company's recently terminated Puerto Rico Electric Power Authority ("PREPA") project.
If you have continuously owned Flotek Industries, Inc. (NYSE: FTK) shares since before August 3, 2026, you may be able to pursue corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. please Visit https://grabarlaw.com/the-latest/flotek-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more. Alternatively, if you purchased shares between August 3, 2026, and August 17, 2026, you can participate in the class action.
What is Alleged? On August 26, 2026, a federal securities fraud class action was filed against Flotek (NYSE: FTK) and certain of its senior officers. The complaint alleges that Flotek made materially false and/or misleading statements and failed to disclose material information concerning a 10-year agreement associated with a 400-megawatt natural gas-fired power generation project for PREPA.
According to the complaint, Flotek announced on August 3, 2026, that it had entered into a 10-year agreement to support the PREPA project and expected the arrangement to generate approximately $400 million in potential revenue backlog. Flotek subsequently highlighted the contract in its quarterly financial results, investor materials and Form 10-Q.
The underlying class action complaint alleges, however, that there were significant questions concerning the experience, organization and financial capacity of certain members of the consortium responsible for the underlying PREPA project. The complaint further recounts allegations that Enchanted Rock, LLC—an entity whose participation allegedly had been relied upon in evaluating the project—later stated that it was not participating in the project and that its name and signature had been used without authorization.
According to Flotek's subsequent public disclosures, the Financial Oversight and Management Board for Puerto Rico ultimately revoked its approval of the underlying power-generation contract and directed PREPA to terminate it. Flotek further disclosed that certain allegations concerning the procurement process had been referred to the Puerto Rico Department of Justice and corresponding federal authorities.
On August 19, 2026, Flotek announced that PREPA had formally terminated the underlying Power Purchase and Operating Agreement, effective immediately. According to Flotek, PREPA identified two independent grounds for termination: the consortium's failure to provide required performance security within the contractual timeframe and the Oversight Board's revocation of its approval.
What is Grabar Law Office's Investigation About? Grabar Law Office is investigating whether Flotek's directors and officers adequately discharged their fiduciary duties in connection with these events, including whether: appropriate due diligence was performed before Flotek assumed significant responsibilities in the PREPA project; Company leadership adequately investigated or responded to potential warning signs concerning the project's consortium participants; material information concerning the project was timely escalated to Flotek's Board of Directors; Flotek maintained adequate internal controls, disclosure controls and risk-management procedures concerning significant new contractual commitments; the Board appropriately oversaw Flotek's expansion into infrastructure-scale power-generation services, an area the Company itself described as an emerging line of business with limited operating history; and Flotek suffered harm as a result of any failures of oversight, disclosure, internal controls or corporate governance.
What Can Flotek Shareholders Do Now? If you have continuously owned Flotek Industries, Inc. (NYSE: FTK) shares since before August 3, 2026, please visit https://grabarlaw.com/the-latest/flotek-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can pursue corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased shares between August 3, 2026, and August 17, 2026, you can participate in the class action. #Flotek #FTK $FTK
GoDaddy Inc. (NYSE: GDDY):
Grabar Law Office is investigating claims on behalf of shareholders of GoDaddy Inc. (NYSE: GDDY).
What is This Investigation About? concerning possible breaches of fiduciary duty and other corporate governance issues involving certain officers and directors of the Company. The investigation follows the filing of a federal securities class action, Johnson v. GoDaddy Inc., et al., No. 26-cv-7144 (S.D.N.Y.), against GoDaddy, Chief Executive Officer Aman Bhutani, and Chief Financial Officer Mark McCaffrey.
Current GoDaddy Inc. (NYSE: GDDY) shareholders who have held shares since before September 3, 2025, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Visit https://grabarlaw.com/the-latest/godaddy-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.
What is Alleged? According to the complaint, GoDaddy Inc. (NYSE: GDDY), via certain of its officers, repeatedly told investors that its strategy was focused on attracting “high-intent” customers and had moved away from discounting at the front end of its customer funnel. The complaint alleges, however, that during the same period the Company had implemented a heavily discounted promotional price for one-year .com domain contracts, which allegedly resulted in shorter-term contracts, lower average order values, and deceleration in total bookings growth.
The complaint further alleges that GoDaddy continued to represent that its high-intent customer strategy was working and that average order size was increasing, while allegedly failing to disclose the impact that the one-year promotional program was having on bookings.
On February 24, 2026, GoDaddy reported its fourth-quarter and full-year 2025 results and disclosed that fourth-quarter total bookings growth had decelerated to 5%, down from 9% in the prior quarter and below analyst expectations. During the associated earnings call, the Company disclosed that it had introduced promotional pricing for one-year .com domains and that the shift in contract term and promotional pricing had reduced upfront bookings and near-term revenue.
Following these disclosures, GoDaddy’s stock price declined from $92.30 per share on February 24, 2026 to $79.12 per share on February 25, 2026, a drop of more than 14%. The accompanying release similarly states that the challenged promotional strategy allegedly contributed to weaker bookings and that GoDaddy’s shares fell more than 14% after the disclosures.
What is Grabar Law Office’s Investigation About? Grabar Law Office is investigating whether certain GoDaddy officers and directors may have breached fiduciary duties owed to the Company or otherwise failed to adequately oversee GoDaddy’s business strategy, public disclosures, financial reporting, and risk-management processes.
Among other things, the investigation concerns whether: Company leadership adequately disclosed the nature and impact of GoDaddy’s promotional discounting strategy; the Board and senior management maintained appropriate oversight over material changes to GoDaddy’s go-to-market strategy; GoDaddy’s disclosure controls were sufficient to ensure that investors received accurate and complete information concerning bookings trends and customer-acquisition practices; certain officers or directors permitted or caused the Company to make materially misleading public statements; and the Company has suffered or may suffer harm through securities litigation, related legal expenses, reputational damage, or other corporate losses.
What Can You Do Now? If you are a current GoDaddy Inc. (NYSE: GDDY) shareholder and have held shares since before September 3, 2025, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Visit https://grabarlaw.com/the-latest/godaddy-shareholder-investigation/, contact Joshua H. Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more. $GDDY #GDDY #Godaddy
The Simply Good Foods Company (NASDAQ: SMPL):
Grabar Law Office is investigating claims on behalf of shareholders of The Simply Good Foods Company (NASDAQ: SMPL).
What is This Investigation About? The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.
If you purchased The Simply Good Foods Company (NASDAQ: SMPL) shares before February 24, 2024, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. You are encouraged to visit https://grabarlaw.com/the-latest/smpl-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.
What is Alleged? As alleged in a recently filed securities fraud class action Complaint, The Simply Good Foods Company (NASDAQ: SMPL), through certain of its officers, made materially false and misleading statements and/or failed to disclose materially adverse facts pertaining to the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) that Simply Good Foods had lost key managerial personnel following the acquisition of OWYN necessary for the successful integration of the acquired OWYN assets; (2) that Simply Good Foods had materially increased its general and administrative spending to compensate for the loss of key managerial personnel; (3) the addition of a new pea protein supplier for OWYN prior to the acquisition had created significant product quality issues which had negatively impacted the product; (4) Simply Good Foods had engaged in promotional activities for OWYN products above its historical practices, eroding margins; (5) that, in order to stem the margin erosion, Simply Good Foods had cut brand support and marketing, further depressing product sales; (6) as a result of the above, the OWYN acquisition had largely failed to achieve its key strategic goals, the integration of OWYN had run into severe operational and execution problems, and the business and operational results for the OWYN segment had been materially negatively impacted, undermining the acquisitions economic rationale; and (7) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
What Can You Do Now? If you purchased The Simply Good Foods Company (NASDAQ: SMPL) shares before February 24, 2024, and still hold shares today, please visit https://grabarlaw.com/the-latest/smpl-shareholder-investigation/, contact Joshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. #SMPL #SimplyGoodFoods $SMPL
Attorney Advertising Disclaimer
Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: 267-507-6085
Email: jgrabar@grabarlaw.com
